MedTrace Logo

Information of the Coma Recovery Scale-Revised for Neurobehavioral State and Recovery of Consciousness Prediction

NCT05819177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2023-04-19

No results posted yet for this study

Summary

Background: The Coma Recovery Scale-Revised (CRS-R) is the most recommended instrument to examine the neurobehavioral condition of individuals with disorders of consciousness (DOCs). Different studies have investigated the prognostic value of the information provided by the conventional administration of the scale, while other measures derived from the scale have been proposed to improve the prognosis of DOCs. However, the heterogeneity of the data used in the different studies prevents a reliable comparison of the identified predictors and measures.

Objectives: This study investigates which information derived from the CRS-R provides the most reliable prediction of both the neurobehavioral state and recovery of consciousness at the discharge of a long-term neurorehabilitation program.

Methods: The clinical records of 171 individuals with DOCs admitted to an inpatient neurorehabilitation program for a minimum of 3 months were used to implement machine learning classifiers that were trained to predict the neurobehavioral state and recovery of consciousness at discharge.

Conditions

  • Disorder of Consciousness

Interventions

OTHER

Rehabilitation program

This group of patients underwent standard rehabilitation programs set by national guidelines.

Sponsors & Collaborators

  • Hospitales Nisa

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819177 on ClinicalTrials.gov